---
figid: PMC7887571__ADVS-8-2002746-g006
figtitle: a) Schematic illustration of the HCJSP prodrug nanoparticle prepared via
  the host–guest interaction between HA‐CD and AD‐SS‐JQ1 and AD‐SS‐PPa
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7887571
filename: ADVS-8-2002746-g006.jpg
figlink: pmc/articles/PMC7887571/figure/advs2285-fig-0006/
number: SF1
caption: a) Schematic illustration of the HCJSP prodrug nanoparticle prepared via
  the host–guest interaction between HA‐CD and AD‐SS‐JQ1 and AD‐SS‐PPa. b) Proposed
  mechanisms of HCJSP‐based combinatory immunotherapy of pancreatic tumor by eliciting
  immunogenicity and overcoming adaptive immune resistance. HCJSP‐mediated PDT initiates
  ICD of the tumor cells, promotes DC maturation, and activates the CTLs for tumor
  regression. Meanwhile, BRD4i JQ1 can relieve PDT‐promoted glycolysis and immunosuppresive
  tumor microenvironment by impeding the transcription of c‐Myc and the downstream
  genes of the c‐Myc pathway, including HK‐2 and LDHA. Meanwhile, JQ1 can specifically
  downregulate IFN‐γ‐inducible PD‐L1 expression on the surface of the tumor cells
  for combating PDT‐inducible adaptive immune evasion.
papertitle: Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting
  Photoimmunotherapy of Pancreatic Cancer.
reftext: Fang Sun, et al. Adv Sci (Weinh). 2021 Feb;8(4):2002746.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9649075
figid_alias: PMC7887571__SF1
figtype: Supplemental figure
redirect_from: /figures/PMC7887571__SF1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7887571__ADVS-8-2002746-g006.html
  '@type': Dataset
  description: a) Schematic illustration of the HCJSP prodrug nanoparticle prepared
    via the host–guest interaction between HA‐CD and AD‐SS‐JQ1 and AD‐SS‐PPa. b) Proposed
    mechanisms of HCJSP‐based combinatory immunotherapy of pancreatic tumor by eliciting
    immunogenicity and overcoming adaptive immune resistance. HCJSP‐mediated PDT initiates
    ICD of the tumor cells, promotes DC maturation, and activates the CTLs for tumor
    regression. Meanwhile, BRD4i JQ1 can relieve PDT‐promoted glycolysis and immunosuppresive
    tumor microenvironment by impeding the transcription of c‐Myc and the downstream
    genes of the c‐Myc pathway, including HK‐2 and LDHA. Meanwhile, JQ1 can specifically
    downregulate IFN‐γ‐inducible PD‐L1 expression on the surface of the tumor cells
    for combating PDT‐inducible adaptive immune evasion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Penk
  - Twist1
  - Hk2
  - Ldha
  - Brd4
  - ac
  - Myc
  - Nol3
  - Mela
  - Gm42368
  - Cd274
  - Calr
  - Slc6a8
  - HACD1
  - HACD2
  - HACD3
  - HACD4
  - HK2
  - KCNA5
  - KIF2A
  - KLK2
  - HOOK2
  - LDHA
  - BRD4
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - GNPTAB
  - MYC
  - ERVW-4
  - CD274
  - CALCR
  - CALR
  - SLC6A8
  - Ppa
  - fs(1)h
  - Polr2A
  - Polr2C
  - Polr2B
  - Polr2I
  - Polr2F
  - Prim1
  - PolA1
  - PolA2
  - sv
  - Prim2
  - svr
  - dc
  - crt
  - oo
  - GSH
  - Oxygen
  - Glucose
  - Lactate
  - Pyruvate
  - Ac
  - Hypoxia - Glucose
  - ICD
---
